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Abstract
Background: The quantification of gene expression in tissue samples requires the use of reference
genes to normalise transcript numbers between different samples. Reference gene stability may
vary between different tissues, and between the same tissue in different disease states. We
evaluated the stability of 9 reference genes commonly used in human gene expression studies. Real-
time reverse transcription PCR and a mathematical algorithm were used to establish which
reference genes were most stably expressed in normal and diseased canine articular tissues and
two canine cell lines stimulated with lipolysaccaride (LPS).
Results: The optimal reference genes for comparing gene expression data between normal and
diseased infrapatella fat pad were RPL13A and YWHAZ (M = 0.56). The ideal reference genes for
comparing normal and osteoarthritic (OA) cartilage were RPL13A and SDHA (M = 0.57). The best
reference genes for comparing normal and ruptured canine cranial cruciate ligament were B2M and
TBP (M = 0.59). The best reference genes for normalising gene expression data from normal and
LPS stimulated cell lines were SDHA and YWHAZ (K6) or SDHA and HMBS (DH82), which had
expression stability (M) values of 0.05 (K6) and 0.07 (DH82) respectively. The number of reference
genes required to reduce pairwise variation (V) to <0.20 was 4 for cell lines, 5 for cartilage, 7 for
cranial cruciate ligament and 8 for fat tissue. Reference gene stability was not related to the level
of gene expression.
Conclusion: The reference genes demonstrating the most stable expression within each different
canine articular tissue were identified, but no single reference gene was identified as having stable
expression in all different tissue types. This study underlines the necessity to select reference genes
on the basis of tissue and disease specific expression profile evaluation and highlights the
requirement for the identification of new reference genes with greater expression stability for use
in canine articular tissue gene expression studies.
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Background
Quantification of gene expression in diseased tissue can
determine genes which are involved in the development
or progression of disease [1], suitable for genomic evalua-
tion [2] or gene based prognostics [3] or treatment [4].
Real-time reverse transcription polymerase chain reaction
(real-time RT-PCR) is the most commonly utilised
method of measuring gene expression in biological sys-
tems. The method provides accurate quantification of
transcript number, good sensitivity over a wide range of
transcript expression levels, and increasing high through-
put capabilities. Several factors contribute to errors of var-
iation in gene expression measurement, including issues
relating to sample starting cell number and sample cell
types, mRNA extraction protocol and handling tech-
niques [5], mRNA quality [6,7], method of reverse tran-
scription [8] and analytical detection chemistry method
[5].
To accommodate these differences in RNA sample prepa-
ration and analysis, the measurement of relative expres-
sion of transcript has evolved a means to control these
variables employing a process that is termed normalisa-
tion [9]. Normalisation of real-time RT-PCR data is classi-
cally performed through the selection of a calibrant
internal control gene, known as a reference gene or
"house-keeping" gene. Conceptually, an ideal gene
selected as an internal reference control should have a
constant level of expression across the tissue or cell sam-
ples used throughout the experiment, and should not
exhibit altered expression with diseased or, control tis-
sues, or indeed experimental conditions [10]. Initially,
ubiquitously applied reference genes were sought that
could be applied across tissue and experimental types [3].
However, recent studies have shown that the expression
stability of some of the commonly used reference genes,
such as B2M, GAPDH and ACTB is not constant for all tis-
sues or disease states [10,11].
Current studies identify reference genes that are validated
for each tissue or cell type and disease or experiment.
These reference genes can be selected by evaluating data
from real-time RT-PCR statistical algorithms, such
geNorm [11], Global Pattern Recognition [12], Bestkeeper
[13], Normfinder [14] or equivalence tests [15]. The prin-
cipal of the geNorm algorithm is that from an initial
group of candidate reference genes tested across all the
types of tissue studied and the experimental conditions,
the expression ratio of the two reference genes that display
the most similar expression identified these genes as the
best choice to monitor variation in test gene expression
[11]. Global Pattern Recognition is a statistical algorithm
which compares the expression or each gene to every
other gene used in the comparison, similar to analysis of
variance (ANOVA) but with exclusion of nonsensical data
(e.g. threshold cycle (CT) values of 40, where no amplifi-
cation has taken place) [12]. The Bestkeeper algorithm
measures the geometric mean of reference gene crossing
point values, to determine the optimal reference gene for
use in a samples set. [13]. Equivalence testing is the math-
ematical determination of the standard deviation of dif-
ferences in expression values between samples being
compared [15]. The Normfinder algorithm uses a model-
based approach to the estimation of expression variation,
which takes into account variation across sub-groups and
avoids the artificial selection of co-regulated genes [14].
Osteoarthritis (OA) is a condition characterised by the
destruction of articular cartilage, resulting in pain and dys-
function of the affected joint. OA is a prevalent disease of
mammalian joints, which affects up to 20% of the canine
population at large [16] with the hip, stifle or elbow joints
most commonly affected. The prevalence of OA on radio-
graphic evaluation of dog populations is much higher,
with estimates of up to 73% of individuals in a single
breed having radiographic evidence of OA of the hip, or a
disease (hip dysplasia) which can lead to OA. [17]. OA
can be experimentally induced in canine joints through
surgical procedures, such as cranial cruciate ligament
transaction [18], and OA associated with naturally occur-
ring cranial cruciate ligament rupture is identified in dogs
[19].
To date, the majority of molecular research into OA has
investigated the mechanisms involved in the catabolism
of articular cartilage. However, OA is not solely a disease
of articular cartilage, as there are changes in other articular
tissues, such as fat [20] and ligaments [21]. The quantifi-
cation of gene expression in all articular connective tis-
sues, such as cartilage [22], cranial cruciate ligament [23],
and infrapatella fat [20] will help to determine the molec-
ular pathogenesis of OA.
In this paper, we identify the best reference genes for use
in real-time RT-PCR experiments investigating gene
expression in canine articular connective tissue studies.
The study draws upon reference genes used in studies eval-
uating dys-regulation of gene expression in human tissue
[11], and employs them to determine if these have similar
application in canine studies. The geNorm algorithm is
employed to investigate the expression stability of 9 com-
monly used reference genes (glyceraldehyde-3-phosphate
dehydrogenase [GAPDH], beta-actin [ACTB], beta-2-
microglobulin [B2M] hydroxymethylbilane synthase
[HMBS], hypoxanthine guanine phosphoribosyl trans-
ferase [HPRT], ribosomal protein L13a [RPL13A], succi-
nate dehydrogenase flavoprotein subunit A [SDHA], TATA
box binding protein [TBP] and tyrosine 3-monooxygen-
ase/tryptophan 5-monooxygenase activation protein, zeta
polypeptide [YWHAZ]) [11] in normal and diseasedBMC Veterinary Research 2007, 3:7 http://www.biomedcentral.com/1746-6148/3/7
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canine connective tissues. We hypothesised that some of
the genes selected would demonstrate stable expression in
the different canine connective tissues investigated and
could therefore be applied as reference genes to normalise
future real-time RT-PCR studies that evaluate gene expres-
sion in canine on connective tissues.
Results
The gene expression levels (threshold cycle, CT) for each
sample group were averaged with standard deviation was
plotted for each group of samples (Figures 1 and 2).
The results for each of the stimulated canine cell lines
demonstrated that optimum reference genes had an M
value of 0.05 (K6; SDHA and YWHAZ) to 0.07 (DH82;
SDHA and HMBS) (Table 1). However, when examining
both cell lines simultaneously, the recommended refer-
ence genes were GAPDH and B2M, and the M value was
increased (0.34, Table 1), indicating reduced stability. Ref-
erence gene expression levels in the K6 cell line appeared
to be higher when compared to DH82 cell lines, with
most of the K6 CT values being less than 30 (Figure 1).
The genes with the highest expression stability for normal
fat pad joints were RPL13A and TBP (M = 0.56), which dif-
fered to OA fat pad (GAPDH and HPRT, M = 0.34) [Table
2]. The expression stability of the ideal reference genes for
use in studies comparing both normal and OA fat pad
(RPL13A and YWHAZ) when analysed together had an M
value of 0.55. The CT results showed a relatively consistent
level of expression for each gene analysed in both sample
groups (Figure 2). One gene (ACTB) was consistently one
of the two least stably expressed genes in both normal and
OA fat and when comparing both groups of tissue.
The optimal reference genes for use in canine articular car-
tilage tissue samples were ACTB and SDHA (M = 0.47) for
normal cartilage, and HPRT and TBP for OA (M = 0.45)
articular cartilage (Table 3). When both sample groups
were analysed together, the expression stability was
reduced (M value = 0.57, Table 3), with SDHA  and
RPL13A identified as the most consistently expressed ref-
erence genes. The expression levels of each investigated
gene in the OA sample group did not demonstrate marked
variation in expression when compared to the CT values of
healthy cartilage (Figure 2). One gene (YWHAZ) was the
least stably expressed in both normal and OA cartilage
and when comparing both groups of tissue.
The expression stability of the optimal reference genes for
normal cranial cruciate ligament tissue (SDHA  and
YWHAZ, M value = 0.26) and diseased tissue (SDHA and
HPRT, M value = 0.33) (see Table 4) were broadly similar.
Analysis of the sample groups together identified reduced
expression stability (0.59) of the two optimal reference
genes (TBP  and  B2M). The CT results demonstrated a
notable decrease in gene expression for B2M and YWHAZ
from the OA sample group (Figure 2).
The ideal number of reference genes required to reduce
pairwise variation (V) to <0.20 was 4 for canine cell lines,
5 for cartilage, 7 for cranial cruciate ligament and 8 for fat
tissue (Figure 3). Addition of further reference genes
below the threshold V value of 0.2 did not greatly reduce
pairwise variation any further. The increase in V values
observed following the hypothetical utilisation of a total
of eight reference genes (canine cell lines) or nine genes
(fat and cartilage) was consistent with previous reports
[11], and has been ascribed to the additional reference
gene(s) having the worst expression stability characteris-
tics [11].
A strong correlation between transcript quantity and refer-
ence gene stability was only identified for one experiment
(LPS stimulation of DH82 cells, R = -0.617). All other
experiments where determined to have low correlation
between reference gene stability and transcript quantity (r
range = 0.238 to -0.280).
Discussion
At present there is no consensus as to which stability algo-
rithm should be used to optimise reference gene stability.
The model based approach is the best for analysing genes
whose function is poorly defined (such as new potential
genes from microarray data), and therefore may have the
potential to be co-regulated as pairwise measurements of
stability will artificially tend to select co-regulated genes
[14]. Comparisons of the different methods of candidate
reference gene selection tend to identify the best and the
worst reference genes consistently [24-26] when evaluat-
Mean expression values (± Standard Deviation [SD]) of  canine cell lines (DH82, K6) before and after lipopolysaccha- ride stimulation (DH82L, K6L), following RT-PCR analysis Figure 1
Mean expression values (± Standard Deviation [SD]) of 
canine cell lines (DH82, K6) before and after lipopolysaccha-
ride stimulation (DH82L, K6L), following RT-PCR analysis.BMC Veterinary Research 2007, 3:7 http://www.biomedcentral.com/1746-6148/3/7
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ing reference genes whose functions are well defined. As
there is no "gold standard" technique for determining the
rank orders of candidate reference genes. We used the
geNorm algorithm because in provided both measures of
individual gene stability, and the measures of pairwise
variation for groups of genes. Furthermore accepted
threshold measures of gene stability and pairwise varia-
tion are well described with this method [11], and the
genes we evaluated have well characterised biological
functions, and for whom no co-regulation has previously
been reported.
To date, limited information has been published on the
selection of appropriate reference genes for use in the
quantification of gene expression in mammalian articular
connective tissues or canine tissues in general. Reports
describing the optimisation of reference genes for use in
canine mammary tumours are published [27], as well as
those for use in prostate, kidney, mammary gland, and left
ventricle of five to nine dogs with or without undefined
diseases [28]. We investigated the stability of reference
genes in a number of different tissues affected by disease
(i.e. tissues from which meaningful comparisons of gene
expression would be made), and therefore for which the
comparison and optimisation of different reference genes
is important.
The expression levels of different reference genes (elonga-
tion factor 1-alpha, GAPDH, actin) have been compared
in human articular cartilage using a crudely quantitative
method, and displayed that the expression level of each
reference gene was raised in OA articular cartilage [29]. To
our knowledge, only one of the reference genes (B2M) we
evaluated to be consistently expressed has been reported
as being differentially expressed in OA articular cartilage
[30]. Yet despite the lack of information on suitable refer-
ence gene selection, the majority of studies quantifying
gene expression in connective tissues use GAPDH as the
Table 1: Canine cell lines (stimulated with LPS) reference genes ranked in order of increasing expression stability (Increases from top 
to bottom).
Number of remaining reference 
genes
Combined Cell lines M Value V Value DH82 Cells M Value V Value K6 Cells M Value V Value
9 ACTB 1.24 0.222 RPL13A 0.83 0.114 ACTB 1.03 0.263
8 HPRT 1.00 0.167 YWHAZ 0.78 0.115 RPL13A 0.64 0.113
7 YWHAZ 0.85 0.125 B2M 0.73 0.142 GAPDH 0.56 0.102
6 HMBS 0.79 0.137 GAPDH 0.62 0.169 HMBS 0.50 0.142
5 SDHA 0.73 0.156 TBP 0.43 0.126 B2M 0.32 0.073
4 RPL13A 0.65 0.175 ACTB 0.29 0.112 HPRT 0.29 0.109
3 TBP 0.54 0.207 HPRT 0.14 0.059 TBP 0.14 0.063
2 Most stably expressed B2M/GAPDH 0.34 HMBS/SDHA 0.07 SDHA/YWHAZ 0.05
Mean expression values for candidate reference genes (± SD) from healthy and diseased canine infrapatellar fat tissue, canine  cartilage and ligament tissue, following RT-PCR analysis Figure 2
Mean expression values for candidate reference genes (± SD) from healthy and diseased canine infrapatellar fat tissue, canine 
cartilage and ligament tissue, following RT-PCR analysis.BMC Veterinary Research 2007, 3:7 http://www.biomedcentral.com/1746-6148/3/7
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reference gene. GAPDH  did not demonstrate stable
expression across all tissues in this study, or in previous
studies of reference gene stability in different canine tis-
sues [27,28]. Indeed, no single reference gene was identi-
fied as having stable expression when analysing the data
from normal and diseased tissues separately and com-
bined, which is also consistent with previous reports eval-
uating canine [28] and human [11] tissue.
The relationship between the stability value of a reference
gene and the CT value of that gene was measured, as genes
which are less abundantly expressed will be more suscep-
tible to errors in measurement due to small variations
from the calculated efficiency values. However, we found
the stability of individual reference genes (M Value)
appears to be unrelated to the level of expression (CT)
which was consistent with a previous report [28], with the
exception of one experiment which was probably a type II
statistical error.
The justification of using the selected genes as reference
genes in canine tissue is based on published work defin-
ing their stability as for use as reference genes with human
tissue [11,31], or canine tissue [28]. The function of these
genes in canine cells is assumed to be the same as that
reported for humans. The expression stability of the two
sets of reference genes within the canine cell lines was
evaluated, using LPS stimulation to mimic biological var-
iation seen between normal and diseased tissue. Interest-
ingly, the expression stability of the reference genes in the
cell lines was much higher than those reported with tissue
samples, (lower M values shown in Table 1) which reflects
the benefits of working with cell cultures compared to
clinical tissue specified. Cell cultures should allow more
control over the heterogeneity of cell type, sample han-
dling, storage and mRNA recovery, thereby minimising
the level of degradation frequently identified with patho-
logical clinical tissue [32], which may in turn affected
gene expression measures [6].
A pair wise variation (V) of 0.15 has been recommended
as an arbitrary cut-off point below which the inclusion of
additional reference genes expression was not required
[11], although this degree of reference gene expression
stability could not be achieved for fat tissue or cranial cru-
ciate ligament. If the selected V value was increased to 0.2,
then pairwise stability could be achieved using between 4
genes (cell lines) and 8 genes (fat tissue). Alternative
measures of disease status, such as histological grading
[33] to further select tissue specimens in comparable
stages of disease may have helped reduce the variability in
reference gene stability, and thus the number of reference
genes required for each experiment.
The selection of candidate genes based on ontological
function, combined with the evaluation gene expression
microarray experiments [25] may reduce the number of
reference gene required to obtain acceptable expression
stability between samples, as clearly the number of genes
suggested are too large to be used in practice. However,
Table 3: Canine cartilage tissue reference genes ranked in order of increasing expression stability (Increases from top to bottom).
Combined M Value V Value Healthy Cartilage M Value V Value OA cartilage M Value V Value
YWHAZ 1.75 0.41 YWHAZ 1.88 0.51 YWHAZ 1.55 0.31
B2M 1.18 0.17 B2M 1.10 0.15 B2M 1.17 0.18
HMBS 1.08 0.17 HPRT 1.02 0.17 HMBS 1.03 0.20
HPRT 0.99 0.15 GAPDH 0.90 0.14 ACTB 0.85 0.15
ACTB 0.95 0.17 TBP 0.86 0.16 RPL13A 0.77 0.17
GAPDH 0.90 0.21 HMBS 0.79 0.20 SDHA 0.68 0.19
TBP 0.84 0.31 RPL13A 0.70 0.26 GAPDH 0.53 0.18
RPL13A/SDHA 0.57 ACTB/SDHA 0.47 HPRT/TBP 0.45
Table 2: Canine infrapatella fat tissue reference genes ranked in order of increasing expression stability (Increases from top to 
bottom).
Combined M Value V Value Normal fat pad M Value V Value OA Fat pad M Value V Value
ACTB 1.57 0.21 ACTB 1.49 0.23 SDHA 1.26 0.15
HMBS 1.43 0.20 HPRT 1.29 0.21 ACTB 1.17 0.18
HPRT 1.31 0.205 HMBS 1.13 0.20 YWHAZ 1.05 0.14
GAPDH 1.20 0.208 GAPDH 0.98 0.17 RPL13A 1.01 0.18
SDHA 1.08 0.23 B2M 0.88 0.23 TBP 0.92 0.19
B2M 0.94 0.28 SDHA 0.65 0.16 B2M 0.82 0.21
TBP 0.70 0.24 YWHAZ 0.57 0.17 HMBS 0.70 0.29
RPL13A/YWHAZ 0.55 RPL13A/TBP 0.56 GAPDH/HPRT 0.34BMC Veterinary Research 2007, 3:7 http://www.biomedcentral.com/1746-6148/3/7
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until these have been identified, this experiment gives an
indication of which genes can be used for the normalisa-
tion of gene expression measures in canine OA tissues,
and which genes are not suitable for normalising real-
time RT-PCR data from fat (ACTB) or cartilage (YWHAZ).
Ultimately, we found that reference gene optimisation has
to be performed on a tissue and disease specific basis,
even when evaluating tissue from the same or similar dis-
eases.
Conclusion
No single reference gene was identified as having stable
expression in all canine articular tissue types. The combi-
nations of reference genes required to demonstrate stable
expression in each tissue were also identified. The number
of genes required to achieve stability for comparing nor-
mal and diseased infrapatella fat and cranial cruciate liga-
ment were inappropriate for routine application. This
study underlines the necessity to select reference genes on
the basis of tissue and disease specific expression evalua-
tion and highlights the requirement for the identification
of new reference genes with greater expression stability for
use in canine articular tissue gene expression studies.
Methods
Cell Line Culture
Canine K6 and DH82 canine cell lines were used in this
study. Cells from the K6 cell line were myelomonocytes
[34], whilst cells derived from the DH82 cell line were of
macrophage-monocytic origin [35]. These cell lines were
cultured and harvested as previously described [36].
Twenty-four hour lipopolysaccharide (LPS) stimulation
of both cell lines was performed by the addition of 100
μg/mL LPS (Salmonella typhimurium; Sigma, Poole, UK) to
the media. Details of cell culture treatments and proce-
dures are available in reference [36]. Cells were harvested
after washing with fresh media by repeated passage of 1
ml of phenol/guanidine HCl reagent (Trizol™; Invitrogen,
Dorset, UK). Total RNA was extracted and isolated using
spin columns (RNeasy; Qiagen Ltd, Crawley, UK) as
described by Reno et al [37].
Tissue Samples
Articular cartilage, cranial cruciate ligament and infrapa-
tella fat samples were obtained from healthy and diseased
dogs. Infrapatella fat samples (n = 5) were obtained from
dogs with clinical OA (secondary to naturally occurring
joint disease). Osteoarthritic articular cartilage samples (n
= 5) were obtained from dogs undergoing total hip
replacement, and ruptured cranial cruciate ligament sam-
ples (n = 5) were obtained from dogs undergoing a rou-
tine surgical procedure (exploratory arthrotomy) for the
treatment of the naturally occurring joint disease, which
radiographic and macroscopic evidence of osteoarthritis.
Control samples (healthy) were obtained from the stifles
(infrapatella fat (n = 5) and cranial cruciate ligament (n =
5) and hips (articular cartilage (n = 5) of dogs of normal
bodyweight euthanized for reasons other than, and with
no evidence of, joint disease. All samples were stored in
RNAlater™ (Ambion Ltd; Huntingdon, UK) at room tem-
perature immediately after harvesting and maintained at -
20°C after 24 hours until use.
Total RNA Extraction
The tissue samples were removed from RNAlater™ and
total RNA was extracted using phenol/guanidine HCl rea-
gents. For (i) cranial cruciate ligament and articular carti-
lage, and (ii) articular fat pad, Trizol™ (Invitrogen Ltd)
and Qiasol (Qiagen Ltd, Crawley, UK) were used respec-
tively, employing the standard instructions as recom-
mended by the manufacturers.
An on column DNA digestion step was included (RNase-
Free DNase Set; Qiagen Ltd). Final elution of the total
RNA was performed using 30 μl of RNase free water, and
repeated to maximise the amount of RNA eluted. Total
RNA samples were stored at -80°C until use. The concen-
tration of total RNA representing each sample was quanti-
Table 4: Canine ligament tissue reference genes ranked in order of increasing expression stability (Increases from top to bottom).
Combined M Value V Value Healthy 
Ligament
M Value V Value Ruptured 
Ligament
M Value V Value
YWHAZ 1.39 0.15 GAPDH 1.28 0.16 RPL13A 1.10 0.17
RPL13A 1.33 0.16 ACTB 1.17 0.19 YWHAZ 0.94 0.16
GAPDH 1.28 0.17 HMBS 1.02 0.25 B2M 0.80 0.15
HMBS 1.22 0.20 B2M 0.71 0.15 GAPDH 0.69 0.14
ACTB 1.15 0.26 HPRT 0.60 0.17 HMBS 0.59 0.11
HPRT 0.98 0.28 TBP 0.41 0.12 TBP 0.57 0.15
SDHA 0.75 0.27 RPL13A 0.31 0.10 ACTB 0.48 0.17
B2M/TBP 0.59 SDHA/
YWHAZ
0.26 HPRT/SDHA 0.33BMC Veterinary Research 2007, 3:7 http://www.biomedcentral.com/1746-6148/3/7
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fied by using a NanoDrop ND1 spectrophotometer
(NanoDrop Technologies Ltd, Utah, USA). RNA integrity
was analysed by evaluating the capillary electrophoresis
trace (Agilent Bioanalyser 2100; Agilent Technology, Cal-
ifornia, USA) of each sample using the RNA integrity
number [RIN] algorithm [38] and Degradation Factor
[DF] [39]. From these quality control calculations, all
RNA samples were determined to have no, or mild, loss of
integrity (RIN > 6.5, and/or DF < 8), and thus deemed
suitable for use in the following experiments [32].
PCR Assay Design
Primer and probe sequences were designed for nine of the
most commonly used control (reference) genes in man
[11] using the Universal Probe Library Assay Design Cen-
tre [40]. Transcript sequences were obtained from the
canine genome database [41], with cross reference to the
National Centre for Biotechnology Information [42].
Primers and matched probes were selected for; glyceralde-
hyde-3-phosphate dehydrogenase [GAPDH], beta-actin
[ACTB], beta-2-microglobulin [B2M] hydroxymethylbi-
lane synthase [HMBS], hypoxanthine guanine phosphori-
Table 5: Sequences for primers and probes for candidate reference genes used in the study (5'-3' direction).
Gene Forward Primer Reverse Primer Probe Amplicon 
Length Bp
Efficiency of 
Assay (%age)
Accession Number for 
sequence used
GAPDH CTGGGGCTCACTTGAAAGG CAAACATGGGGGCATCAG CTGCTCCT 72 102.3 NM_001003142
ACTB CCCATCTACGAGGGGTACG GGATCTTCATGAGGTAGTCAGTCA CTGGCTGG 88 101.9 NM_001003349
B2M CCTTGCTCCTCATCCTCCT TGGGTGTCGTGAGTACACTTG CAGCATCC 83 99.5 XM_535458
HMBS GCATGTATGCTGTGGGTCAG GCATGTCCTGGTCCTTGG GGCCCTGG 63 101.0 XM_546491
HPRT TGTGCTCAAGGGAGGCTATAA CCATCACTATTTCTGTTCAGTGCT ACCTGCTG 75 101.8 NM_001003357
RPL13A CTGCCCCACAAGACCAAG GGGATCCCATCAAACACCT CCAGGCTG 65 98.6 ENSCAFG00000003633
SDHA GGTGGCACTTCTACGACACC ATGTAGTGGATGGCGTCCTG CTGGCTGG 67 102.5 XM_535807
TBP TCCACAGCCTATCCAGAACA CTGCTGCTGTTGTCTCTGCT CTGGAGGA 67 97.4 ENSCAFG00000004119
YWHA
Z
GTTACTTGGCCGAAGTTGCT TGCTTGTTGTGACTGATCCAC TGGTGATG 65 100.7 XM_532287
Pairwise variation analysis for determining optimal number of reference genes in various canine tissues (healthy and diseased) Figure 3
Pairwise variation analysis for determining optimal number of reference genes in various canine tissues (healthy and diseased).
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bosyl transferase [HPRT], ribosomal protein L13a
[RPL13A], succinate dehydrogenase flavoprotein subunit
A [SDHA], TATA box binding protein [TBP] and tyrosine
3-monooxygenase/tryptophan 5-monooxygenase activa-
tion protein, zeta polypeptide [YWHAZ] (Table 5). Basic
Local Alignment Search Tool [42] searches were per-
formed for all primer sequences to confirm gene specifi-
city. To enhance the probability of transcript-specific PCR,
selected amplicon systems were designed so that the last
six to seven bases of a 3' primer or the probe crossed an
exon-exon boundary. When this was not possible, the
primers were designed to be hybridised on different
exons, with an intronic sequence greater than 1,100 base
pairs, to maintain specificity for mRNA. Some assays
could be designed within only a single exon, and thus a
genomic DNA assay [43] was also used to determine
whether genomic contamination was present. No
genomic DNA was identified in any sample. The specifi-
city of primer sets was further confirmed through micro-
fluidic capillary electrophoresis (using the Agilent 2100
Bioanalyzer, Agilent Technologies UK Ltd, South Queens-
ferry, West Lothian, UK) to measurement quantify the size
of any product(s) generated by the real-time RT-PCR reac-
tion. For each probe and primer set a single band of the
expected size was identified (Figure 4). 5' reporter dye
FAM (6-carboxy fluorescein) and dark quencher dye
probes were synthesized by Exiqon (Vedbaek, Denmark),
and primers were synthesized by Metabion International
AG (Martinsried, Germany).
Reverse Transcription
Reverse transcription was performed using 200 ug total
RNA with oligo-dT and Superscript II reverse transcriptase
(Invitrogen). The real-time PCR assays were all performed
in triplicate using a TaqMan™ ABI PRISM 7700 SDS
(Applied Biosystems, California, USA) employing 96-well
plates, and no template controls were used for each assay.
Each assay well had a 20 μL reaction volume consisting of
10  μL 2 × PCR master mix with uracil N-glycosylase
(Applied Biosystems), 3.8 μL of sterile distilled water, and
0.4 μL each of 20 μM forward and reverse primers, 0.4 μL
of 20 μM probe (Exiqon, Vedbaek, Denmark) and 5 μL of
sample cDNA (templates) or water (negative controls).
The amplification was performed according to the stand-
ard protocol with 40 cycles of 95°C for 15 sec and 60°C
for 1 min as recommended by the manufacturer (Applied
Biosystems). Real-time data was analyzed by using the
Sequence Detection Systems software, version 1.6.3
(Applied Biosystems). Standard curves were generated
from five repeated ten-fold serial dilutions of cDNA.
Data Analysis
Following the RT-PCR assays, the CT values for each of the
candidate reference genes were converted into relative
quantities using the algorithm described by Vandesom-
pele et al [11]. These relative quantities were then entered
into a data input file which could be analyzed by the
geNorm software package to identify which of the assayed
genes for a given tissue type exhibited the most stable rel-
ative expression. Gene expression stability measures (M
value) of each individual gene within the tissue evaluated
was calculated by the geNorm software. The pairwise var-
iation (V Value), which is an indication of the influence
on the stability attributed by addition of a gene to a group
of reference genes, was also calculated by the geNorm soft-
ware package. Genes with the lowest M value are the most
stably expressed. Pairwise variation between samples is
(usually) reduced by the inclusion of additional reference
genes thus it is an indication of the number of genes
required to achieve and arbitrarily selected measure of ref-
erence gene stability. To determine the effect of expression
level on gene expression stability, correlations between
the level of expression (CT value) and reference gene sta-
bility (M value) were performed using a Spearmans rank
correlation coefficient (Minitab 14.0, State College PA,
USA).
Spearman rank correlation coefficients were calculated for
each experiment to determine the interaction between
transcript quantity (CT value) and reference gene stability
(rank order, as determined in tables 1, 2, 3, 4).
Abbreviations
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hydroxymethylbilane synthase, HPRT  = hypoxanthine
guanine phosphoribosyl transferase, RPL13A = ribosomal
protein L13a, SDHA = succinate dehydrogenase flavopro-
tein subunit A, TBP  = TATA box binding protein and
YWHAZ  = tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta polypeptide, CT =
Threshold cycle, ANOVA = Analysis of variance, LPS =
Lipopolysaccaride, V = Pairwise variation, M = Gene Sta-
bility Value, RIN = RNA integrity number, DF = Degrada-
tion Factor, RT-PCR = reverse transcription polymerase
chain reaction, OA = Osteoarthritis
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